Heat therapy study for warts in special groups
Part of Infections, Skin clinical trials.
This study tests whether heat therapy (hyperthermia) can help treat viral warts in people who are pregnant, have HIV/AIDS, autoimmune diseases, diabetes, take immune-suppressing drugs, or are children. It aims to find a safe and effective option for these groups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have viral warts and are pregnant, or have AIDS, an autoimmune disease, or diabetes.
- You are a child with viral warts.
- You are taking immunosuppressant drugs for your viral warts.
- You or your legal guardian can understand and sign a consent form.
- You do not have a tumor or other serious illness that would prevent you from completing the study.
- You can commit to treatment sessions and follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether applying heat combined with a common disinfectant (hydrogen peroxide) can safely and effectively remove viral skin warts. It may be an option if you have common, plantar, or genital warts and are between 16 and 65 years old.
This study tests a new patch that combines gentle heat with hydrogen peroxide to treat common warts on hands, feet, or fingers. The patch is applied directly to the wart and may help your body clear the infection.
This study tests whether cantharidin—a liquid applied directly to common warts—can safely and effectively remove them. Common warts are bumpy growths caused by a virus that appear on hands, feet, and other body areas.
This trial tests a medication called cantharidin for treating common warts. It is for people age 2 and older who are generally healthy and have at least one common wart on the body (but not on palms, soles, face, or genitals). Participants cannot use other wart treatments during the study.
This Phase 2 study tests giving a Candida antigen plus a bivalent HPV vaccine to help shrink or clear multiple common skin warts. It may help people with warts on different body areas, with different sizes or how long they’ve had them.
This study tests whether an HPV vaccine can help shrink or clear cutaneous (skin) warts that have not responded to prior treatments. Participants get the study vaccine or a placebo to compare results and safety.
Hear when a new Warts trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.